Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Muto, Carlene A.
Jernigan, John A.
Ostrowsky, Belinda E.
Richet, Hervé M.
Jarvis, William R.
Boyce, John M.
and
Farr, Barry M.
2003.
SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains ofStaphylococcus aureusandEnterococcus.
Infection Control & Hospital Epidemiology,
Vol. 24,
Issue. 5,
p.
362.
Allen, George
2003.
Helicobacter pylori; bowel cleansing; carbon dioxide suctioning; mupirocin‐resistant Staphylococcus aureus.
AORN Journal,
Vol. 78,
Issue. 4,
p.
676.
Farr, Barry M
2004.
The state of the science.
American Journal of Infection Control,
Vol. 32,
Issue. 2,
p.
106.
Lobbedez, T.
Gardam, M.
Dedier, H.
Burdzy, D.
Chu, M.
Izatt, S.
Bargman, J. M.
Jassal, S. V.
Vas, S.
Brunton, J.
and
Oreopoulos, D. G.
2004.
Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
Nephrology Dialysis Transplantation,
Vol. 19,
Issue. 12,
p.
3140.
Lio, Peter A
and
Kaye, Elaine T
2004.
Topical antibacterial agents.
Infectious Disease Clinics of North America,
Vol. 18,
Issue. 3,
p.
717.
Ochsner, Urs A.
Young, Casey L.
Stone, Kimberley C.
Dean, Frank B.
Janjic, Nebojsa
and
Critchley, Ian A.
2005.
Mode of Action and Biochemical Characterization of REP8839, a Novel Inhibitor of Methionyl-tRNA Synthetase.
Antimicrobial Agents and Chemotherapy,
Vol. 49,
Issue. 10,
p.
4253.
Rotger, Margalida
Trampuz, Andrej
Piper, Kerryl E.
Steckelberg, James M.
and
Patel, Robin
2005.
Phenotypic and Genotypic Mupirocin Resistance among Staphylococci Causing Prosthetic Joint Infection.
Journal of Clinical Microbiology,
Vol. 43,
Issue. 8,
p.
4266.
Critchley, Ian A.
Young, Casey L.
Stone, Kimberley C.
Ochsner, Urs A.
Guiles, Joseph
Tarasow, Ted
and
Janjic, Nebojsa
2005.
Antibacterial Activity of REP8839, a New Antibiotic for Topical Use.
Antimicrobial Agents and Chemotherapy,
Vol. 49,
Issue. 10,
p.
4247.
Rouse, Mark S.
Rotger, Margalida
Piper, Kerryl E.
Steckelberg, James M.
Scholz, Matthew
Andrews, Jeffrey
and
Patel, Robin
2005.
In Vitro and In Vivo Evaluations of the Activities of Lauric Acid Monoester Formulations against
Staphylococcus aureus
.
Antimicrobial Agents and Chemotherapy,
Vol. 49,
Issue. 8,
p.
3187.
Nicholson, Mary R.
and
Huesman, Laura A.
2006.
Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients.
American Journal of Infection Control,
Vol. 34,
Issue. 1,
p.
44.
Saiful, A. J.
Mastura, M.
Zarizal, S.
Mazurah, M. I.
Shuhaimi, M.
and
Ali, A. M.
2006.
Detection of Methicillin-Resistant Staphylococcus aureus Using mecA/nuc Genes and Antibiotic Susceptibility Profile of Malaysian Clinical Isolates .
World Journal of Microbiology and Biotechnology,
Vol. 22,
Issue. 12,
p.
1289.
Napolitano, Lena M.
2006.
Decolonization of the Skin of the Patient and Surgeon.
Surgical Infections,
Vol. 7,
Issue. supplement 3,
p.
s-3.
Coia, J.E.
Duckworth, G.J.
Edwards, D.I.
Farrington, M.
Fry, C.
Humphreys, H.
Mallaghan, C.
and
Tucker, D.R.
2006.
Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.
Journal of Hospital Infection,
Vol. 63,
Issue. ,
p.
S1.
Critchley, Ian A.
2006.
Eradication of MRSA nasal colonization as a strategy for infection prevention.
Drug Discovery Today: Therapeutic Strategies,
Vol. 3,
Issue. 2,
p.
189.
Loveday, H.P.
Pellowe, C.M.
Jones, S.R.L.J.
and
Pratt, R.J.
2006.
A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996–2004): report to the Joint MRSA Working Party (Subgroup A).
Journal of Hospital Infection,
Vol. 63,
Issue. ,
p.
S45.
Caierão, Juliana
Berquó, Laura
Dias, Cícero
and
d'Azevedo, Pedro Alves
2006.
Decrease in the incidence of mupirocin resistance among methicillin-resistant Staphylococcus aureus in carriers from an intensive care unit.
American Journal of Infection Control,
Vol. 34,
Issue. 1,
p.
6.
Talbot, G. H.
Bradley, J.
Edwards, J. E.
Gilbert, D.
Scheld, M.
and
Bartlett, J. G.
2006.
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.
Clinical Infectious Diseases,
Vol. 42,
Issue. 5,
p.
657.
Yang, Jin Ah
Park, Dae Won
Sohn, Jang Wook
Yang, In Seok
Kim, Kyung Hyun
and
Kim, Min Ja
2006.
Molecular Analysis of Isoleucyl-tRNA Synthetase Mutations in Clinical Isolates of Methicillin-Resistant Staphylococcus aureus with Low-Level Mupirocin Resistance.
Journal of Korean Medical Science,
Vol. 21,
Issue. 5,
p.
827.
Gemmell, Curtis G.
Edwards, David I.
Fraise, Adam P.
Gould, F. Kate
Ridgway, Geoff L.
and
Warren, Rod E.
2006.
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.
Journal of Antimicrobial Chemotherapy,
Vol. 57,
Issue. 4,
p.
589.
Bertrand, Xavier
2006.
Methicillin-resistant Staphylococcus aureus in elderly care facilities.
Aging Health,
Vol. 2,
Issue. 1,
p.
37.